Our Publications.
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis
While some studies have shown that the long-term use of anti-psychotic medications lowers the risk of relapse for patients with schizophrenia spectrum disorders. However, other work has questioned the being on these medications long-term might worse people’s overall functioning. In this study, we explored whether the use of anti-psychotic medication is associated with lower work disability in patients experiencing their first episode of non-affective psychosis and for how long.
Balancing Risks and Benefits of Cannabis Use: Umbrella Review of Meta-Analyses of Randomised Controlled Trials and Observational Studies
In this article, we explore the relationship between cannabis, cannabinoids (the components of cannabis), cannabis-based medicines and human health. To do this, we conducted an umbrella review of randomized controlled trials (RCTs) and observational studies.
Age at Onset of Mental Disorders Worldwide: Large-Scale Meta-Analysis of 192 Epidemiological Studies
Promoting good mental health before someone develops a mental health disorder has been shown to improve their outcomes. However, the age ranges for when mental health disorders first start has not been well documented in the literature. To address this, we conducted a global systematic review of 192 studies to get a picture of when these issues typically begin.